FAQs for the interim clinical considerations for COVID-19 vaccination

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

FAQs for the interim clinical considerations for COVID-19 vaccination

06/14/2023
By National Center for Immunization and Respiratory Diseases (U.S.)

[PDF-489.09 KB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)
Content Notes:

Vaccine Use and Schedule -- Vaccine Dosage and Formulation -- Age Transitions -- People who are Moderately or Severely Immunocompromised -- Vaccination and SARS-CoV-2 Laboratory Testing -- Vaccination and SARS-CoV-2 Infection -- Special Populations and Situations.
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Vaccination Vaccination Coverage
Document Type:

Webpage
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:d173e46f7c411398ddb471544dc2448fc97d307e883690375a7deafb62404c83
Download URL:

https://stacks.cdc.gov/view/cdc/130305/cdc_130305_DS1.pdf
File Type:

faq.html

htm

More +